JP Morgan Chase
TNYA icon

JP Morgan Chase’s Tenaya Therapeutics TNYA Stock Holding History

JP Morgan Chase’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Buy
20,032
+2,082
+12% +$1.58K ﹤0.01% 6802
2026
Q1 		$11.1K Buy
17,950
+4,123
+30% +$3.04K ﹤0.01% 6711
2025
Q4 		$9.84K Buy
13,827
+13,308
+2,564% +$18.1K ﹤0.01% 6680
2025
Q3 		$841 Buy
+519
New +$523 ﹤0.01% 6997
2025
Q2 		– Sell
-2,258,512
Closed -$1.29M – 7642
2025
Q1 		$1.29M Sell
2,258,512
-2,897,084
-56% -$2.86M ﹤0.01% 4176
2024
Q4 		$7.37M Buy
5,155,596
+5,130,774
+20,670% +$11.5M ﹤0.01% 3003
2024
Q3 		$47.9K Buy
24,822
+661
+3% +$1.87K ﹤0.01% 6008
2024
Q2 		$74.9K Buy
24,161
+5,232
+28% +$21.6K ﹤0.01% 5678
2024
Q1 		$99K Sell
18,929
-10,927
-37% -$52.3K ﹤0.01% 5683
2023
Q4 		$96.7K Sell
29,856
-8
-0% -$17 ﹤0.01% 5745
2023
Q3 		$76.2K Sell
29,864
-5,821
-16% -$24.4K ﹤0.01% 5638
2023
Q2 		$209K Buy
35,685
+1,017
+3% +$5.91K ﹤0.01% 5046
2023
Q1 		$99K Buy
34,668
+17,351
+100% +$48.8K ﹤0.01% 5438
2022
Q4 		$35K Buy
17,317
+21
+0.1% +$51 ﹤0.01% 5726
2022
Q3 		$50K Buy
17,296
+617
+4% +$2.88K ﹤0.01% 5551
2022
Q2 		$94K Sell
16,679
-5,197
-24% -$42K ﹤0.01% 5440
2022
Q1 		$258K Buy
21,876
+9,647
+79% +$117K ﹤0.01% 5056
2021
Q4 		$232K Buy
12,229
+5,503
+82% +$120K ﹤0.01% 5272
2021
Q3 		$139K Buy
+6,726
New +$145K ﹤0.01% 5407

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase's TNYA Position: Q2 2026 in Review

JP Morgan Chase increased its Tenaya Therapeutics (TNYA) stake by 12% in Q2 2026, buying an estimated $1.58K and bringing the position to 20,032 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6802.

JP Morgan Chase first reported a position in TNYA in Q3 2021 and has held it in 19 quarters since. The position peaked at $7.37M in Q4 2024. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • JP Morgan Chase held 20,032 shares of Tenaya Therapeutics worth $14.7K as of Q2 2026.
  • JP Morgan Chase bought 2,082 Tenaya Therapeutics shares in Q2 2026, an estimated $1.58K.
  • Tenaya Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6802 holding.
  • JP Morgan Chase first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Tenaya Therapeutics position peaked at $7.37M in Q4 2024.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.